The popularity of these medicines is unprecedented
LillyDirect Acceptance by LillyDirect and NovoCare is contingent on meeting their prescribing criteria: to reduce excess body weight and maintain weight reduction long term in adults with obesity (BMI 30) or adults with overweight (BMI 27) with at least one weight-related comorbid condition such as Diabetes, hypertension, or high cholesterol
By comparison, those taking Wegovy the highest-dose semaglutide formulation approved for weight loss lost up to 17.4% in a similar time period (68 weeks)
Combined with clinical biomarkers (fasting glucose, lipids, HbA1c, weight loss rate), genetic insights can help your provider design a treatment plan that accounts for your unique metabolic contextpotentially reducing trial-and-error adjustments and supporting evidence-based decisions about discontinuation or maintenance timelines
Nibber A, Singh H, Burnet P, Lennox B, Minichino A
Tirzepatide is one of the newest and most effective medications available for chronic weight management